For most Indian families, a sore throat first meets a glass of warm turmeric milk before it ever meets a pharmacy. This instinct to reach for a kitchen remedy reflects something larger: a medical tradition thousands of years old that still shapes how millions stay well. Traditional medicine is not a relic competing with hospitals and laboratories. Increasingly, it is being studied, validated, and woven into mainstream healthcare. Understanding how these ancient systems feed into modern medicine reveals a powerful story about science, policy, and the future of treatment.
Table of Contents
- What traditional medicine brings to the table
- The major systems and their approaches
- From traditional remedies to modern pharmaceuticals
- Why drug discovery still looks to tradition
- Integrating traditional medicine into mainstream healthcare
- The WHO push for evidence-based integration
- The role of collaboration between healers and researchers
- Challenges and ethical questions
- Evidence, safety, and standardisation
- Protecting traditional knowledge
What traditional medicine brings to the table
Traditional medicine refers to the knowledge, skills, and practices used to maintain health and treat illness that have been passed down through generations within different cultures. It includes formal systems like Ayurveda, Siddha, Unani, and Traditional Chinese Medicine, as well as countless indigenous and folk healing practices. The World Health Organization now groups these under the broader label of traditional, complementary and integrative medicine, recognising both their cultural depth and their potential clinical value.
The scale of reliance is striking. Studies of health-seeking behaviour suggest that over 80 percent of people across both low- and high-income countries turn to some form of traditional or complementary medicine for their health needs. This is not a fringe preference. For large populations, especially in rural and underserved areas, traditional practitioners are often the first and most accessible point of care.
The major systems and their approaches
Each system carries a distinct philosophy. Ayurveda emphasises balance among bodily energies and focuses heavily on diet, daily routine, and prevention. Siddha, rooted in the Tamil tradition, and Unani, derived from Greco-Arabic medicine, offer their own diagnostic frameworks and herbal formulations. What unites these systems is a holistic outlook: they treat the person rather than only the disease, and they place strong value on preventing illness before it appears. This preventive, lifestyle-centred approach is precisely where modern medicine, often criticised for being reactive, has much to learn.
From traditional remedies to modern pharmaceuticals
One of the strongest arguments for taking traditional medicine seriously is that modern pharmacology owes it an enormous debt. A surprising number of life-saving drugs began as plants used by traditional healers, later isolated and refined by chemists.
Consider malaria. Quinine, the first effective antimalarial, came from the bark of the cinchona tree, long used by indigenous communities in the Amazon to treat fevers. Centuries later, artemisinin, today the foundation of frontline malaria therapy, was isolated from Artemisia annua, a herb described in classical Chinese medical texts as a fever remedy. The scientist behind that discovery, Tu Youyou, was awarded the Nobel Prize in 2015, a moment that signalled how seriously the scientific establishment now treats traditional knowledge.
India’s own botanical heritage has been just as generous. Reserpine, an early drug for high blood pressure and certain psychiatric conditions, was extracted from Rauwolfia serpentina, known as Indian snakeroot and used in Ayurveda for centuries. Other examples documented in studies of ethnobotany include morphine and codeine from the opium poppy, the cancer drugs vincristine and vinblastine from the Madagascar periwinkle, and digoxin from foxglove. In each case, a remedy noticed and refined by traditional users became a standardised medicine for the world.
Why drug discovery still looks to tradition
This is not just history. Pharmaceutical researchers continue to screen plants named in traditional texts because doing so dramatically narrows the search. Instead of testing molecules at random, scientists begin with species that healers already associate with healing fevers, wounds, or pain. This ethnobotanical lead saves time and money, and it keeps traditional knowledge central to twenty-first-century drug discovery.
Integrating traditional medicine into mainstream healthcare
The most ambitious developments are happening at the level of policy. Rather than keeping traditional and modern medicine in separate silos, governments are trying to make them work together within a single health system.
In India, this effort is led by the Ministry of AYUSH, an acronym for Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homoeopathy. Through the National AYUSH Mission, traditional medicine services are being co-located within existing public health facilities, and dedicated Health and Wellness Centres are being established to bring these systems closer to communities. The ministry has also set up integrated departments in major hospitals so that patients can access both conventional and traditional care under one roof.
What makes this more than symbolic is the research behind it. Government bodies have run feasibility studies on integrating Ayurveda with modern medicine in tertiary hospitals for conditions such as knee osteoarthritis, and on introducing traditional interventions into reproductive and child health programmes at the primary care level. Siddha formulations like Nilavembu Kudineer have been deployed during dengue and chikungunya outbreaks. These pilots are slowly building the evidence needed to justify integration on a larger scale.
The WHO push for evidence-based integration
This is part of a global movement. In 2025, the World Health Assembly adopted the Global Traditional Medicine Strategy 2025-2034, which sets four objectives: strengthen the evidence base, ensure safety and regulation, integrate traditional medicine into health systems, and capture its wider social value. The strategy carefully insists that ancient practices earn their place through modern scientific testing rather than tradition alone.
India holds a notable position in this story. The WHO’s Global Traditional Medicine Centre, the organisation’s first knowledge hub dedicated to the field, is located in Jamnagar, Gujarat. The momentum is reflected in policy too: by 2023, 90 of 106 countries surveyed reported having national policies on traditional medicine, a sharp rise from just 25 in 1999, according to analysis of the strategy.
The role of collaboration between healers and researchers
None of this works without genuine partnership between traditional practitioners and medical scientists. The two communities have historically spoken different languages. A healer may describe a treatment in terms of balance and constitution, while a researcher demands controlled trials and measurable outcomes. Bridging this gap is the central challenge of integration.
Collaboration matters for several practical reasons. Healers hold detailed knowledge about which plants and combinations are used for which conditions, knowledge that would take researchers decades to gather independently. Researchers, in turn, can test these claims rigorously, identify active compounds, and establish safe dosages. When the two work together, the result is treatment that is both rooted in tradition and validated by evidence. This widens the range of options available to patients and can improve outcomes, particularly for chronic conditions where conventional medicine alone offers limited relief.
Challenges and ethical questions
Integration is promising, but it is far from straightforward. Several serious obstacles stand in the way, and ignoring them would do a disservice to both patients and practitioners.
Evidence, safety, and standardisation
The biggest scientific hurdle is that traditional systems often do not fit neatly into conventional research methods. Ayurveda, for instance, treats each person individually and delivers therapy as a whole package of diet, herbs, and lifestyle, which is difficult to test through a standard trial designed to isolate a single variable. As one policy analysis notes, the lack of research methods suited to these complex interventions slows the generation of solid evidence. Add to this the variation in herbal quality, the risk of contamination, and inconsistent regulation, and the need for strong safety standards becomes clear. Validation is not a barrier to respect traditional medicine; it is the path to using it responsibly.
Protecting traditional knowledge
There is also an ethical dimension that India has confronted directly. When traditional remedies become commercially valuable, foreign companies have sometimes tried to patent them, a practice critics call biopiracy. In the 1990s, a US patent was granted for using turmeric to heal wounds, and patents were filed abroad on neem-based products, despite both being used in Indian households for generations. India successfully challenged these, with scientists submitting ancient Sanskrit and Urdu texts as proof of prior knowledge.
These episodes led to the creation of the Traditional Knowledge Digital Library, a searchable database of documented Indian medicinal knowledge that patent examiners worldwide can access. By making this knowledge visible as established prior art, the library helps prevent unjust patents before they are granted. It is a reminder that integrating traditional medicine into the modern economy must go hand in hand with protecting the communities and cultures that created it, and with fair benefit-sharing when their knowledge generates profit.
Traditional medicine, then, is neither a substitute for modern healthcare nor a superstition to be dismissed. It is a vast reservoir of accumulated wisdom that, tested carefully and integrated thoughtfully, can expand what medicine is able to offer. The challenge for the coming decade is to honour that wisdom while holding it to the same standards of evidence and safety that protect every patient.
What do you think? Should traditional treatments be required to pass the same clinical trials as modern drugs before being offered in public hospitals, or do their holistic, individualised methods call for an entirely different way of measuring success? And as traditional knowledge becomes more commercially valuable, who should rightfully own and benefit from remedies that have belonged to whole communities for centuries?
References
- https://www.who.int/publications/i/item/9789240113176
- https://www.science.org/doi/10.1126/science.3887571
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967429/
- https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1629515/full
- https://www.pib.gov.in/PressReleasePage.aspx?PRID=2114965
- https://www.who.int/teams/who-global-traditional-medicine-centre/overview
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12578523/
- https://www.mondaq.com/india/patent/586384/traditional-knowledge-and-patent-issues-an-overview-of-turmeric-basmati-neem-cases
Leave a Reply